Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

01-12-2021 | Hypertension | Research

The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study

Prevalence of H type hypertension

Authors: Xiao-lin Qian, Hong Cao, Jun Zhang, Zhi-hui Gu, Wei-qin Tang, Lei Shen, Jia-lu Hu, Zhi-feng Yao, Lei Zhang, Min-na Tang, Xu-cheng Lv, Jun Zhou, Xue-juan Jin, Bin Hong, Zhao-qiang Cui, Jun-bo Ge

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

H type hypertension is defined as homocysteine (Hcy) ≥ 10 μmol/L in combination with primary hypertension. Studies demonstrated that the existence of hyperhomocysteine (HHcy) in hypertensive exacerbates the poor outcome of cardiocerebral incidents. This study was to investigate the current epidemic situation of H type hypertension and determine the risk factors in order to find intervention targets for H type hypertensives.

Methods

We conducted a cross-sectional study using cluster sampling design in Shanghai, China from July 2019 and April 2020. 23,652 patients with primary hypertension were enrolled in this study. Their medical information was recorded, and the level of Hcy concentrations and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms were detected.

Results

In total, 22,731 of 23,652 patients were recorded. The mean age was 68.9 ± 8.6 y and 43% were men. 80.0% of the enrolled patients had H type hypertension. The frequency of allele T was 40.9%, and the proportions of the CC, CT, and TT genotypes were 36.1%, 46.0%, and 17.9%, respectively. Compared with the TT genotype, the plasma Hcy concentration levels were lower in patients with the CC/CT genotype (18.96 ± 13.48 μmol/L vs. 13.62 ± 5.20/14.28 ± 5.36, F = 75.04, p < 0.01). The risk for H type hypertension was higher in elderly people. Men had ~ 5.55-fold odds of H type hypertension compared with women. Patients with CT genotype and TT genotype had ~ 1.36- and ~ 2.76-fold odds of H type hypertension compared with those with CC genotype, respectively. Smoking and diabetes were not significantly associated with H type hypertension.

Conclusions

The prevalence of H type hypertension in patients with primary hypertension was 80.0%, which was higher than the 75% found in prior report in China. Age, gender, and MTHFR C677T polymorphisms rather than smoking and diabetes were independently associated with H type hypertension.
Literature
1.
go back to reference McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–28.PubMedPubMedCentral McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56:111–28.PubMedPubMedCentral
2.
go back to reference Zhong C, Lv L, Liu C, Zhao L, Zhou M, Sun W, et al. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS ONE. 2014;9:e107498.PubMedPubMedCentralCrossRef Zhong C, Lv L, Liu C, Zhao L, Zhou M, Sun W, et al. High homocysteine and blood pressure related to poor outcome of acute ischemia stroke in Chinese population. PLoS ONE. 2014;9:e107498.PubMedPubMedCentralCrossRef
3.
go back to reference Li T, Zhu J, Fang Q, Duan X, Zhang M, Diao S, et al. Association of H-type hypertension with stroke severity and prognosis. Biomed Res Int. 2018;2018:8725908.PubMedPubMedCentral Li T, Zhu J, Fang Q, Duan X, Zhang M, Diao S, et al. Association of H-type hypertension with stroke severity and prognosis. Biomed Res Int. 2018;2018:8725908.PubMedPubMedCentral
4.
go back to reference Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A, et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci Lond. 2009;118:187–94.PubMedCrossRef Zhang W, Sun K, Chen J, Liao Y, Qin Q, Ma A, et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin Sci Lond. 2009;118:187–94.PubMedCrossRef
5.
go back to reference Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8:Cd006612.PubMed Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017;8:Cd006612.PubMed
6.
go back to reference Jotoku M, Okura T, Miyoshi K, Irita J, Nagao T, Kukida M, et al. Carotid hemodynamics is associated with monocyte count determined by serum homocysteine level in patients with essential hypertension. Clin Exp Hypertens. 2015;37:358–63.PubMedCrossRef Jotoku M, Okura T, Miyoshi K, Irita J, Nagao T, Kukida M, et al. Carotid hemodynamics is associated with monocyte count determined by serum homocysteine level in patients with essential hypertension. Clin Exp Hypertens. 2015;37:358–63.PubMedCrossRef
7.
go back to reference Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298:153–7.PubMedCrossRef Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010;298:153–7.PubMedCrossRef
8.
go back to reference Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol. 2002;156:1105–13.PubMedCrossRef Lim U, Cassano PA. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988–1994. Am J Epidemiol. 2002;156:1105–13.PubMedCrossRef
9.
go back to reference Liu J, Quan J, Li Y, Wu Y, Yang L. Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: a STROBE-compliant observational study. Medicine. 2018;97:e12626.PubMedPubMedCentralCrossRef Liu J, Quan J, Li Y, Wu Y, Yang L. Blood homocysteine levels could predict major adverse cardiac events in patients with acute coronary syndrome: a STROBE-compliant observational study. Medicine. 2018;97:e12626.PubMedPubMedCentralCrossRef
10.
go back to reference Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation. 2004;109:2766–72.PubMedCrossRef Iso H, Moriyama Y, Sato S, Kitamura A, Tanigawa T, Yamagishi K, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation. 2004;109:2766–72.PubMedCrossRef
11.
go back to reference Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526–33.PubMedCrossRef Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA. 1995;274:1526–33.PubMedCrossRef
12.
go back to reference Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis. 2002;164:321–8.PubMedCrossRef Moriyama Y, Okamura T, Kajinami K, Iso H, Inazu A, Kawashiri M, et al. Effects of serum B vitamins on elevated plasma homocysteine levels associated with the mutation of methylenetetrahydrofolate reductase gene in Japanese. Atherosclerosis. 2002;164:321–8.PubMedCrossRef
13.
go back to reference Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr. 2007;137:407–13.PubMedCrossRef Hao L, Ma J, Zhu J, Stampfer MJ, Tian Y, Willett WC, et al. High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status. J Nutr. 2007;137:407–13.PubMedCrossRef
14.
go back to reference Jiang S, Chen Q, Venners SA, Zhong G, Hsu YH, Xing H, et al. Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia. Cardiovasc Ther. 2013;31:e27-33.PubMedCrossRef Jiang S, Chen Q, Venners SA, Zhong G, Hsu YH, Xing H, et al. Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemia. Cardiovasc Ther. 2013;31:e27-33.PubMedCrossRef
15.
go back to reference Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27:517–27.PubMedCrossRef Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27:517–27.PubMedCrossRef
16.
go back to reference Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–6.PubMedCrossRef Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–6.PubMedCrossRef
17.
go back to reference Harris S, Rasyid A, Kurniawan M, Mesiano T, Hidayat R. Association of high blood homocysteine and risk of increased severity of ischemic stroke events. Int J Angiol. 2019;28:34–8.PubMedCrossRef Harris S, Rasyid A, Kurniawan M, Mesiano T, Hidayat R. Association of high blood homocysteine and risk of increased severity of ischemic stroke events. Int J Angiol. 2019;28:34–8.PubMedCrossRef
18.
go back to reference Hu DY. Xu XP [Prevention of stroke relies on valid control “H” type hypertension]. Zhonghua Nei Ke Za Zhi. 2008;47:976–7.PubMed Hu DY. Xu XP [Prevention of stroke relies on valid control “H” type hypertension]. Zhonghua Nei Ke Za Zhi. 2008;47:976–7.PubMed
19.
go back to reference Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in chinese adults: a prospective, nested case-control study. J Transl Int Med. 2015;3:171–8.PubMedPubMedCentralCrossRef Li J, Jiang S, Zhang Y, Tang G, Wang Y, Mao G, et al. H-type hypertension and risk of stroke in chinese adults: a prospective, nested case-control study. J Transl Int Med. 2015;3:171–8.PubMedPubMedCentralCrossRef
20.
go back to reference Huh HJ, Chi HS, Shim EH, Jang S, Park CJ. Gene–nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Thromb Res. 2006;117:501–6.PubMedCrossRef Huh HJ, Chi HS, Shim EH, Jang S, Park CJ. Gene–nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population. Thromb Res. 2006;117:501–6.PubMedCrossRef
21.
go back to reference Mahfouz RA, Cortas NK, Charafeddine KM, Abdul Khalik RN, Sarieddine DS, Kadi RH, et al. Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults. Gene. 2012;504:175–80.PubMedCrossRef Mahfouz RA, Cortas NK, Charafeddine KM, Abdul Khalik RN, Sarieddine DS, Kadi RH, et al. Correlation of methylenetetrahydrofolate reductase polymorphisms with homocysteine metabolism in healthy Lebanese adults. Gene. 2012;504:175–80.PubMedCrossRef
22.
go back to reference Sadewa AH, Sunarti Sutomo R, Hayashi C, Lee MJ, Ayaki H, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci. 2002;48:137–44.PubMed Sadewa AH, Sunarti Sutomo R, Hayashi C, Lee MJ, Ayaki H, et al. The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population. Kobe J Med Sci. 2002;48:137–44.PubMed
23.
go back to reference Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs. 2001;1:353–61.PubMedCrossRef Nakai K, Itoh C, Nakai K, Habano W, Gurwitz D. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD. Am J Cardiovasc Drugs. 2001;1:353–61.PubMedCrossRef
24.
go back to reference Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032–6.PubMedCrossRef Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032–6.PubMedCrossRef
25.
go back to reference Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, et al. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48:1183–90.PubMedCrossRef Zhao M, Wang X, He M, Qin X, Tang G, Huo Y, et al. Homocysteine and stroke risk: modifying effect of methylenetetrahydrofolate reductase C677T polymorphism and folic acid intervention. Stroke. 2017;48:1183–90.PubMedCrossRef
26.
go back to reference Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137:2344–56.PubMedCrossRef Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137:2344–56.PubMedCrossRef
27.
go back to reference Qu QG, Gao JJ, Liu JM. Prevalence of hyperhomocysteinaemia in a Chinese elderly population. Public Health Nutr. 2010;13:1974–81.PubMedCrossRef Qu QG, Gao JJ, Liu JM. Prevalence of hyperhomocysteinaemia in a Chinese elderly population. Public Health Nutr. 2010;13:1974–81.PubMedCrossRef
28.
go back to reference Yang B, Fan S, Zhi X, Wang Y, Wang Y, Zheng Q, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients. 2014;7:74–90.PubMedPubMedCentralCrossRef Yang B, Fan S, Zhi X, Wang Y, Wang Y, Zheng Q, et al. Prevalence of hyperhomocysteinemia in China: a systematic review and meta-analysis. Nutrients. 2014;7:74–90.PubMedPubMedCentralCrossRef
29.
go back to reference Zhang Z, Fang X, Ji X, Tang Z, Wang C, Qian H, et al. [The prevalence and relative risk factors of H type hypertension in elderly patients living in Beijing.] Chin J Postgrad Med. 2018;41:443–8. (in Chinese). Zhang Z, Fang X, Ji X, Tang Z, Wang C, Qian H, et al. [The prevalence and relative risk factors of H type hypertension in elderly patients living in Beijing.] Chin J Postgrad Med. 2018;41:443–8. (in Chinese).
30.
go back to reference Liu H. [The investigation of hyperhomocysteinemia in patients with primary hypertension living in Daxing district of Beijing.] Chin J Rural Med Pharm. 2016;23:64–5. (in Chinese) Liu H. [The investigation of hyperhomocysteinemia in patients with primary hypertension living in Daxing district of Beijing.] Chin J Rural Med Pharm. 2016;23:64–5. (in Chinese)
31.
go back to reference Yan Z, Wang Y, Li S, Wang J, Zhang L, Tan H, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Am J Hypertens. 2018;31:486–94.PubMedCrossRef Yan Z, Wang Y, Li S, Wang J, Zhang L, Tan H, et al. Hypertension control in adults with CKD in China: baseline results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). Am J Hypertens. 2018;31:486–94.PubMedCrossRef
33.
go back to reference Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44:437–45.PubMedCrossRef Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44:437–45.PubMedCrossRef
34.
go back to reference Zhou Y, Qi H, Zhao GM, Yang LM. Sun Q [Relationship between hyperuricemia and chronic kidney disease in Pudong New Area of Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:351–5.PubMed Zhou Y, Qi H, Zhao GM, Yang LM. Sun Q [Relationship between hyperuricemia and chronic kidney disease in Pudong New Area of Shanghai]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33:351–5.PubMed
35.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.PubMedCrossRef Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815–22.PubMedCrossRef
36.
go back to reference Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GHJ. Homocysteine, vitamin status and risk of vascular disease. Effects of gender and menopausal status. Eur Heart J. 1999;20:1234–44.PubMedCrossRef Verhoef P, Meleady R, Daly LE, Graham IM, Robinson K, Boers GHJ. Homocysteine, vitamin status and risk of vascular disease. Effects of gender and menopausal status. Eur Heart J. 1999;20:1234–44.PubMedCrossRef
37.
go back to reference Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab. 1998;83:550–3.PubMedCrossRef Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females. J Clin Endocrinol Metab. 1998;83:550–3.PubMedCrossRef
38.
go back to reference Taskin G, Yilmaz Sipahi E, Yildirimkaya M, Nadirler F, Halloran M, Ayoglu FN, et al. Plasma total homocysteine levels in a healthy Turkish population sample. Acta Cardiol. 2006;61:35–42.PubMedCrossRef Taskin G, Yilmaz Sipahi E, Yildirimkaya M, Nadirler F, Halloran M, Ayoglu FN, et al. Plasma total homocysteine levels in a healthy Turkish population sample. Acta Cardiol. 2006;61:35–42.PubMedCrossRef
39.
go back to reference Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630–5.PubMedCrossRef Hao L, Ma J, Stampfer MJ, Ren A, Tian Y, Tang Y, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630–5.PubMedCrossRef
40.
go back to reference Russo GT, Di Benedetto A, Giorda C, Alessi E, Crisafulli G, Ientile R, et al. Correlates of total homocysteine plasma concentration in type 2 diabetes. Eur J Clin Invest. 2004;34:197–204.PubMedCrossRef Russo GT, Di Benedetto A, Giorda C, Alessi E, Crisafulli G, Ientile R, et al. Correlates of total homocysteine plasma concentration in type 2 diabetes. Eur J Clin Invest. 2004;34:197–204.PubMedCrossRef
41.
go back to reference Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000;23:1816–22.PubMedCrossRef Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000;23:1816–22.PubMedCrossRef
42.
go back to reference Passaro A, D’Elia K, Pareschi PL, Calzoni F, Carantoni M, Fellin R, et al. Factors influencing plasma homocysteine levels in type 2 diabetes. Diabetes Care. 2000;23:420–1.PubMedCrossRef Passaro A, D’Elia K, Pareschi PL, Calzoni F, Carantoni M, Fellin R, et al. Factors influencing plasma homocysteine levels in type 2 diabetes. Diabetes Care. 2000;23:420–1.PubMedCrossRef
43.
go back to reference Russo GT, Di Benedetto A, Magazzù D, Giandalia A, Giorda CB, Ientile R, et al. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetol. 2011;48:95–101.PubMedCrossRef Russo GT, Di Benedetto A, Magazzù D, Giandalia A, Giorda CB, Ientile R, et al. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study. Acta Diabetol. 2011;48:95–101.PubMedCrossRef
44.
go back to reference McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res. 1996;83:195–8.PubMedCrossRef McAndrew PE, Brandt JT, Pearl DK, Prior TW. The incidence of the gene for thermolabile methylene tetrahydrofolate reductase in African Americans. Thromb Res. 1996;83:195–8.PubMedCrossRef
45.
go back to reference Pollak RD, Friedlander Y, Pollak A, Idelson M, Bejarano Achache I, Blumenfeld A. Ethnic differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in healthy Israeli populations. Genet Test. 2000;4:309–11.PubMedCrossRef Pollak RD, Friedlander Y, Pollak A, Idelson M, Bejarano Achache I, Blumenfeld A. Ethnic differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in healthy Israeli populations. Genet Test. 2000;4:309–11.PubMedCrossRef
46.
go back to reference Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J. 2012;11:2.PubMedPubMedCentralCrossRef Qin X, Li J, Cui Y, Liu Z, Zhao Z, Ge J, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults. Nutr J. 2012;11:2.PubMedPubMedCentralCrossRef
47.
go back to reference Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520–6.PubMedCrossRef Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520–6.PubMedCrossRef
48.
go back to reference Yuan M, Wang B, Tan S. Mecobalamin and early functional outcomes of ischemic stroke patients with H-type hypertension. Rev Assoc Med Bras. 1992;2018(64):428–32. Yuan M, Wang B, Tan S. Mecobalamin and early functional outcomes of ischemic stroke patients with H-type hypertension. Rev Assoc Med Bras. 1992;2018(64):428–32.
49.
go back to reference Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9.PubMedCrossRef Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9.PubMedCrossRef
Metadata
Title
The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study
Prevalence of H type hypertension
Authors
Xiao-lin Qian
Hong Cao
Jun Zhang
Zhi-hui Gu
Wei-qin Tang
Lei Shen
Jia-lu Hu
Zhi-feng Yao
Lei Zhang
Min-na Tang
Xu-cheng Lv
Jun Zhou
Xue-juan Jin
Bin Hong
Zhao-qiang Cui
Jun-bo Ge
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02151-x

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue